Join Us at 1 pm Eastern/10 am Pacific for RNAi “Tweetchat” with Alnylam’s John Maraganore

Here’s just a quick reminder that we’re doing the live Tweetchat today with Alnylam Pharmaceuticals CEO John Maraganore. This chat, which anyone with a Twitter account is free to join, will be held today at 1 pm Eastern/10 am Pacific. The best way to follow the questions and answers will be to follow the live stream of questions and answers on Twitter at #RNAichat. I will be asking questions from my account (@ldtimmerman) while Maraganore will be offering up answers at @alnylam.

Anyone else on Twitter who like to send in a question about the latest ups and downs in RNA interference is welcome to fire away at #RNAichat, sort of like how people do at a press conference or an investor breakout session. For those of you who don’t have Twitter accounts, but would like to see how a real-time online chat unfolds, you can see it here at this post on Xconomy. Those of you who aren’t on Twitter who would like to send a question in to Maraganore can just send me an e-mail at [email protected].

This is an experiment of sorts that we’re trying, which I hope will be a fun and informative way to expand the conversation online in biotech. See you here at 1 pm Eastern/10 am Pacific.

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.